Cholangiocarcinoma Market is Estimated to grow at a CAGR of 4.2% during the forecast period
The cholangiocarcinoma market was estimated to be worth USD 1.9 billion globally in 2022, and over the forecast period, a CAGR of 4.2% is anticipated. This is a very uncommon kind of cancer that appears in the area known as the bile duct, a tiny tube that joins the small intestine, gall bladder, and liver. The industry is expanding significantly due to rising healthcare costs and increased health awareness. The market is expanding due to combination therapy and the rising use of medications with minimal side effects. Significant market expansion is being driven by growing awareness of cholangiocarcinoma. Cholangiocarcinoma is one of the most incurable forms of cancer due to the high cost of therapy. Growing therapeutic approaches like immunotherapy, targeted therapy, and innovative medication treatments are propelling the market's rapid expansion. The market is expanding significantly due to ongoing research and development efforts by pharmaceutical companies and research inst...